Ivd Antibodies Market Analysis

IVD Antibodies Market: Global Industry Analysis 2013 - 2017 and Opportunity Assessment; 2018 - 2028


  • US$5,000
  • US$7,500
  • US$10,000

This Ivd Antibodies market study offers a comprehensive analysis of the business models, key strategies, and respective market shares of some of the most prominent players in this landscape. Along with an in-depth commentary on the key influencing factors, market statistics in terms of revenues, segment-wise data, region-wise data, and country-wise data are offered in the full study. This study is one of the most comprehensive documentation that captures all the facets of the evolving Ivd Antibodies market.

In vitro diagnostics tests are used in laboratories, healthcare settings or directly by consumers at home for the detection of various diseases, infections and other medical conditions. Various companies in the IVD antibodies market are focusing on mergers and acquisitions with regional players. For example, in Sep. 2018, Summa Equity AB acquired Turku-based HyTest Ltd. whose regional presence in the U.S. and Asia is good. Continuously evolving nature of IVD antibodies market further expected to get maximum traction. Superior capability of the IVD antibodies to detect complex diseases such as cancer and use of IVD antibodies in therapeutic monitoring, evaluating blood safety before transfusion further makes it preferred choice of diagnosis test.

IVD Antibodies Market: Drivers and Restraints

Increasing incidence of chronic diseases such as HIV, hepatitis, cancer, cardiovascular diseases, etc. expected to drive the growth of IVD antibodies market. Incidence of cancer and cardiovascular diseases is increasing rapidly and hence aging population of world further expected to drive the growth of IVD antibodies market. The ease of use of IVD antibodies for the diagnosis at laboratories, hospitals or even at home further increases patient compliance and makes IVD antibodies preferred choice.

Market Growth Analysis

Disclaimer: This data is only a representation. Actual data may vary and will be available in the report.

IVD Antibodies Market:
Global Industry Analysis 2013 - 2017 and Opportunity Assessment; 2018 - 2028

The IVD antibodies market is further driven by increasing research and development funding which in turn improving the outcome of diagnostic tests as well as manufacturing of high end quality IVD antibodies for assays. Manufacturers in the IVD antibodies market are focusing on mergers, acquisitions, collaborations and agreements such as Sebia Inc. one of the major IVD manufacturing company signed an agreement with Janssen Biotech to develop multiple myeloma IVD test. Whereas, low product penetration and higher cost of the IVD antibodies may hamper the potential growth of the market. Although manufacturers are focusing on developing novel IVD antibodies for diagnosis of different diseases but time consuming nature of research and development and tedious product approval process may hamper the growth of market.

IVD Antibodies Market: Overview

The global IVD antibodies market is majorly driven by the increasing chronic disease incidence as well as increasing product penetration in the low and middle income countries. By product type, IVD antibodies market is expected to be dominated by the tumor markers due to high adoption for the diagnosis of malignancies. By the application, the IVD antibodies market is dominated by the cancer due to high number of diagnostic procedures. By end user, IVD antibodies market is dominated by the diagnostic laboratories due to high patient footfall for the disease diagnosis. The increasing R & D expenditure by leading biopharmaceutical companies for the development and evaluation of IVD antibodies for different diagnosis of various diseases expected to impact the market significantly.

IVD Antibodies Market: Regional Outlook

The global IVD antibodies market is dominated by North America due to higher product penetration. Europe is expected to be the second most lucrative IVD antibodies market due to higher number of diagnostic procedure and favorable reimbursement scenario. Latin America is expected to experience steady market growth due to increasing IVD antibodies adoption for the diagnostic procedures. Asia-Pacific is emerging market in IVD antibodies due to rapidly increasing product penetration, and emerging countries such India and China where healthcare infrastructure evolving rapidly. Middle East and Africa is expected to be least revenue generating IVD antibodies market due to low product penetration as well as limited availability of good healthcare infrastructure in most of the MEA region.

IVD Antibodies Market: Key Players

The key market participants operating in the IVD antibodies market are: Abcam plc., Thermo Fisher Scientific, Rockland Immunochemicals Inc., GenScript, Bio-Rad Laboratories, Inc., SDIX, LLC., Advy Chemical Pvt. Ltd., MEDICAL & BIOLOGICAL LABORATORIES CO., LTD., HyTest Ltd., Abbott and Others

The research report presents a comprehensive assessment of the IVD Antibodies market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to IVD Antibodies market segments such as geographies, application, and industry.

The report covers exhaust analysis on:

  • IVD Antibodies Market Segments
  • IVD Antibodies Market Dynamics
  • IVD Antibodies Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Indication
  • Value Chain

Regional analysis includes:

  • North America (U.S., Canada)
  • Latin America (Mexico. Brazil)
  • Western Europe (Germany, Italy, France, U.K, Spain)
  • Eastern Europe (Poland, Russia)
  • Asia-Pacific excluding Japan (China, India, ASEAN, Australia & New Zealand)
  • Japan
  • Middle East and Africa (GCC Countries, South Africa, Northern Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Competitive Positioning Matrix

Disclaimer: This data is only a representation. Actual data may vary and will be available in the report.

Average Selling Price (ASP) Analysis

Disclaimer: This data is only a representation. Actual data may vary and will be available in the report.

IVD Antibodies Market: Segmentation

The global IVD antibodies market is segmented based on the product type, application, end user and region

By product type IVD antibodies market is segmented as:

  • Cardiac Markers
  • Tumor Markers
  • Kidney Injury Markers
  • Infection and Inflammation Antibodies

By application, IVD antibodies market is segmented as:

  • Immunology
  • Cancer
  • Cardiovascular Diseases

By end user IVD antibodies market is segmented as:

  • Hospitals
  • Diagnostic Laboratories
  • Homecare settings
  • Others

Report Highlights:

  • Detailed overview of parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current, and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
  • Must-have information for market players to sustain and enhance their market footprint
Get in touch
Harish Tiwari

Harish Tiwari

Global Head - Business Development

Pranay Mhaisekar

Pranay Mhaisekar

Business Development

* indicates mandatory fields
Our Clients

Request Sample Request customization Request Methodology